Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Labeling of MDIs

Posted on By

SOP for Labeling of MDIs

MDI Labeling Guidelines

1) Purpose

The purpose of this SOP is to establish the procedures for labeling metered-dose inhalers (MDIs) to ensure accuracy, compliance with regulatory requirements, and clear communication of product information to end users.

2) Scope

This SOP applies to all personnel involved in the labeling of MDIs at the manufacturing facility, including labeling operators, supervisors, and quality assurance staff.

3) Responsibilities

The responsibilities for this SOP include ensuring correct labeling of MDIs, maintaining labeling equipment, and documenting the labeling process. Specific roles include:
Labeling Operators: Perform the labeling operations as outlined.
Supervisors: Monitor the labeling process and ensure compliance.
Quality Assurance: Inspect and verify the labeling process.

See also  SOP for Propellant Testing in MDIs

4) Procedure

4.1 Preparation
4.1.1 Verify the labeling materials against the bill of materials.
4.1.2 Set up the labeling equipment according to the manufacturer’s instructions.
4.1.3 Clean the labeling area to prevent contamination.
4.2 Labeling Process
4.2.1 Load the MDIs onto the labeling machine.
4.2.2 Ensure the correct alignment and application of labels on each MDI.
4.2.3 Perform in-process checks to verify label accuracy, position, and adhesion.
4.3 Quality Checks

/> 4.3.1 Inspect labeled MDIs for any labeling defects (e.g., misalignment, incorrect information).
4.3.2 Record the inspection results in the labeling logbook.
4.4 Reconciliation
4.4.1 Reconcile the number of labels used with the number of MDIs labeled.
4.4.2 Investigate and document any discrepancies.
4.5 Documentation
4.5.1 Maintain records of labeling batch numbers, dates, and quantities.
4.5.2 Ensure all records are reviewed and approved by quality assurance.

See also  SOP for Homogeneity Testing in MDIs

5) Abbreviations, if any

MDI: Metered-Dose Inhaler

6) Documents, if any

Labeling records, equipment maintenance logs, and inspection reports should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for labeling standards.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Uniformity of Dosage Units in Transdermal Patches
Next Post: SOP for Homogeneity Testing in Lotions

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version